Key Insights on Johnson & Johnson's Dividend Ahead of May 27, 2025 Ex-Dividend Date

Johnson & Johnson (JNJ) has announced a forthcoming dividend of $1.300 per share, with an ex-dividend date set for May 27, 2025, and a payment date on Jun 10, 2025. This amount is notably higher compared to the average of the last ten dividends, which stands at approximately $0.456. The announcement was made on Apr 15, 2025. The last dividend issued by the company on Mar 4, 2025, was $1.240 per share. The consistent increase in dividend payouts reflects the company's strong financial health and commitment to returning value to shareholders.

Recently, Johnson & Johnson has been actively engaged in several significant initiatives. The company expanded its efforts to support the global nursing workforce through the new social impact platform, J&J CareCommunity. In the area of cancer research, promising new data was unveiled from its portfolio concerning hematologic malignancies and solid tumors, marking a significant step in innovative cancer treatments. Additionally, Johnson & Johnson MedTech announced the U.S. launch of the SOUNDSTAR CRYSTAL™ Ultrasound Catheter, a device designed to enhance intracardiac echocardiography imaging in cardiac ablation procedures. This development underscores the company's commitment to advancing medical technology and improving patient outcomes.

Over the past week, Johnson & Johnson has also been in the spotlight due to a favorable vote from the FDA's Oncologic Drugs Advisory Committee for its product DARZALEX FASPRO®, aimed at treating high-risk conditions. Amid these developments, the company's stock experienced a slight decline, closing at $152.51, representing a -0.44% adjustment from the previous day's close. However, analysts maintain a positive outlook, with a consensus rating of Moderate Buy and an average price target of $169.50, implying an upside potential.

In conclusion, Johnson & Johnson's recent strategic moves and robust dividend policy highlight its stable financial performance and innovative prowess. Investors should note that May 27, 2025, is the ex-dividend date, the last opportunity to purchase shares and receive the upcoming dividend. Any acquisitions after this date will not qualify for the current dividend payout.